Establishment Labs Holdings (ESTA) Cost of Revenue (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Cost of Revenue came in at $17.5 million in Q1 2026, up 29.28% year-on-year from $13.6 million in Q1 2025, and down 8.08% quarter-over-quarter from $19.1 million in Q4 2025.
Establishment Labs Holdings (ESTA) Cost of Revenue (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cost of Revenue history runs 10 years deep, the most recent figure standing at $17.5 million for Q1 2026.
- On a quarterly basis, Cost of Revenue rose 29.28% year-over-year to $17.5 million in Q1 2026; TTM through Mar 2026 was $68.7 million, a 20.0% increase from a year earlier, with the FY2025 full-year figure at $64.8 million, up 14.63% from the prior year.
- Cost of Revenue slipped to $17.5 million in Q1 2026 per ESTA's latest filing, from $19.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $19.1 million in Q4 2025 and bottomed at $11.0 million in Q4 2023.
- The 5-year median for Cost of Revenue is $14.5 million (2024), against an average of $14.8 million.
- Across the five-year window, Cost of Revenue jumped 41.14% in 2022 and dropped 29.86% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $15.6 million in 2022, then fell by 29.86% to $11.0 million in 2023, then increased by 27.76% to $14.0 million in 2024, then soared by 36.11% to $19.1 million in 2025, then dropped by 8.08% to $17.5 million in 2026.
- Per Business Quant, the three latest ESTA Cost of Revenue figures stand at $17.5 million (Q1 2026), $19.1 million (Q4 2025), and $16.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 17.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.54 Mn |
| Mar 31, 2026 | 17.54 Mn |
| Dec 31, 2025 | 19.09 Mn |
| Dec 31, 2025 | 19.09 Mn |
| Sep 30, 2025 | 16.09 Mn |
| Sep 30, 2025 | 16.09 Mn |
| Jun 30, 2025 | 16.03 Mn |
| Jun 30, 2025 | 16.03 Mn |
| Mar 31, 2025 | 13.57 Mn |
| Mar 31, 2025 | 13.57 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Sep 30, 2024 | 14.51 Mn |
| Sep 30, 2024 | 14.51 Mn |
| Jun 30, 2024 | 15.18 Mn |
| Jun 30, 2024 | 15.18 Mn |
| Mar 31, 2024 | 12.79 Mn |
| Mar 31, 2024 | 12.79 Mn |
| Dec 31, 2023 | 10.98 Mn |
| Dec 31, 2023 | 10.98 Mn |